Screener
Royalty Pharma RPRX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's total debt?
- Royalty Pharma (RPRX) reported total debt of $8.96B in Q2 2026.
- How has Royalty Pharma's total debt changed year-over-year?
- Royalty Pharma's total debt increased by 11.7% year-over-year, from $8.02B to $8.96B.
- What is the long-term trend for Royalty Pharma's total debt?
- Over 5 years (2020 to 2025), Royalty Pharma's total debt has grown at a 9.1% compound annual growth rate (CAGR), from $5.82B to $8.97B.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Royalty Pharma's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude